Covered recipient · General Payments record
JOEL K JAGER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2021
$709.27
- Reported across 48 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $418.60 | 28 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $147.29 | 14 |
| DEXCOM, INC. | $59.70 | 3 |
| Biohaven Pharmaceuticals, Inc. | $41.47 | 1 |
| PFIZER INC. | $35.15 | 2 |
| Amgen Inc. | $34.38 | 2 |
| Abbott Laboratories | $21.15 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.50 | 1 |
| Paratek Pharmaceuticals, Inc. | $16.82 | 1 |
| Teva Pharmaceuticals USA, Inc. | $15.87 | 1 |
| Esperion Therapeutics, Inc. | $14.84 | 1 |
| GlaxoSmithKline, LLC. | $12.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2021 201820192020
Record-level detail is published for PY2021; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $21.15 | 08/30/2021 | Food and Beverage | Undisputed | 01/23/2026 | 833739395 | CMS |
| AbbVie Inc. | $10.48 | 01/07/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794940761 | CMS |
| AbbVie Inc. | $11.35 | 02/11/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794940765 | CMS |
| AbbVie Inc. | $9.93 | 03/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794940769 | CMS |
| AbbVie Inc. | $13.20 | 04/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794940773 | CMS |
| AbbVie Inc. | $11.06 | 05/06/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794940777 | CMS |
| AbbVie Inc. | $16.13 | 05/20/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794940781 | CMS |
| AbbVie Inc. | $2.53 | 06/11/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794940785 | CMS |
| AbbVie Inc. | $12.24 | 08/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794940789 | CMS |
| AbbVie Inc. | $8.93 | 08/27/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794940793 | CMS |
| AbbVie Inc. | $3.91 | 09/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794940797 | CMS |
| AbbVie Inc. | $14.10 | 09/28/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794940801 | CMS |
| AbbVie Inc. | $13.28 | 11/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794940805 | CMS |
| AbbVie Inc. | $18.72 | 11/11/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794940809 | CMS |
| AbbVie Inc. | $1.43 | 11/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794940813 | CMS |
| Amgen Inc. | $17.53 | 06/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 825424637 | CMS |
| Amgen Inc. | $16.85 | 08/30/2021 | Food and Beverage | Undisputed | 01/23/2026 | 825424643 | CMS |
| Biohaven Pharmaceuticals, Inc. | $41.47 | 02/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | 852526147 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.50 | 05/17/2021 | Food and Beverage | Undisputed | 01/23/2026 | 763675416 | CMS |
| DEXCOM, INC. | $16.63 | 09/21/2021 | Food and Beverage | Undisputed | 01/23/2026 | 845282275 | CMS |
| DEXCOM, INC. | $24.28 | 10/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 845282277 | CMS |
| DEXCOM, INC. | $18.79 | 11/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | 845282279 | CMS |
| Esperion Therapeutics, Inc. | $14.84 | 04/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | 838318961 | CMS |
| GlaxoSmithKline, LLC. | $12.43 | 10/05/2021 | Food and Beverage | Undisputed | 01/23/2026 | 802775027 | CMS |
| Paratek Pharmaceuticals, Inc. | $16.82 | 07/20/2021 | Food and Beverage | Undisputed | 01/23/2026 | 813508531 | CMS |
| PFIZER INC. | $13.28 | 06/02/2021 | Food and Beverage | Undisputed | 01/23/2026 | 832520505 | CMS |
| PFIZER INC. | $21.87 | 11/02/2021 | Food and Beverage | Undisputed | 01/23/2026 | 833168719 | CMS |
| Teva Pharmaceuticals USA, Inc. | $15.87 | 03/02/2021 | Food and Beverage | Undisputed | 01/23/2026 | 839603677 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.